During the past decade, Hôpital de la Timone, Oncologie Pédiatrique conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital de la Timone, Oncologie Pédiatrique" are "Solid Tumors" (2 trials), "ALK Fusion-positive Solid or CNS Tumors" (1 trials), "CNS Tumors" (1 trials), "High Grade Glioma" (1 trials) and "Sarcoma" (1 trials). Many other conditions were trialed in "Hôpital de la Timone, Oncologie Pédiatrique" in a lesser frequency.

Most popular intervention types in "Hôpital de la Timone, Oncologie Pédiatrique" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (1 trials), "Bevacizumab" (1 trials), "Cobimetinib" (1 trials), "Entrectinib" (1 trials) and "Radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital de la Timone, Oncologie Pédiatrique" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital de la Timone, Oncologie Pédiatrique". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital de la Timone, Oncologie Pédiatrique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital de la Timone, Oncologie Pédiatrique, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".